Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stepan (SCL) Shares Outstanding (Diluted Average) (2020 - 2025)

Stepan (SCL) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $22.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) changed 0.18% year-over-year to $22.9 million, compared with a TTM value of $22.9 million through Dec 2025, changed 0.18%, and an annual FY2025 reading of $22.9 million, changed 0.18% over the prior year.
  • Shares Outstanding (Diluted Average) was $22.9 million for Q4 2025 at Stepan, roughly flat from $22.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $23.3 million in Q4 2021 and bottomed at $22.9 million in Q4 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $23.0 million, with a median of $22.9 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Diluted Average) rose 0.13% in 2021, then fell 0.96% in 2022.
  • Year by year, Shares Outstanding (Diluted Average) stood at $23.3 million in 2021, then dropped by 0.96% to $23.1 million in 2022, then fell by 0.51% to $22.9 million in 2023, then dropped by 0.07% to $22.9 million in 2024, then fell by 0.18% to $22.9 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for SCL at $22.9 million in Q4 2025, $22.9 million in Q4 2024, and $22.9 million in Q3 2024.